|
Status |
Public on Mar 01, 2016 |
Title |
ChIP-4b_mutant-input |
Sample type |
SRA |
|
|
Source name |
Oral cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
cell: T3M-1 Cl-10 genotype: L211M chip antibody: none
|
Extracted molecule |
genomic DNA |
Extraction protocol |
T3M-1 Cl-10 cells were infected with a mock retrovirus or virus generated from pMXS-ires-EGFP expressing FLAG-epitope–tagged ELF4 or ELF4(L211M). ChIP was conducted with anti-FLAG M2 antibody (Sigma-Aldrich). The precipitated DNA fragments were subjected to massively parallel sequencing with Genome Analyzer IIx (Illumina) for 51 bases from both ends of the fragments. ChIP-seq libraries were prepared using Illumina NEBNext ChIP-Seq Library Prep Reagent Set following the manufacturer's protocols.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina Genome Analyzer IIx |
|
|
Description |
mutant_qv30_E_0_peak.cod
|
Data processing |
Basecalls performed using CASAVA version 1.6.0 Sequenced reads were selected for high-quality read (quality value >=30), and mapped to hg19 whole genome using bowtie v0.12.7 with parameters -q -n 0 -l 50 -p 30 --k 1 -X 500. Mapped results were converted to ALN files by using bowtie2aln in CisGenome v2.0. Peaks were calculated using CisGenome with the following setting: Read Extension Length E (0). Motifs were calculated using CisGenome with the following setting: No.of Motifs (30), No. of MCMC iterations (1000). Genome_build: hg19 Supplementary_files_format_and_content: Peaks (*.cod) were tab-delimited text files.
|
|
|
Submission date |
Dec 16, 2013 |
Last update date |
May 15, 2019 |
Contact name |
Mizuo Ando |
E-mail(s) |
ando.hnc@gmail.com
|
Phone |
03-3815-5411
|
Organization name |
The University of Tokyo
|
Department |
Otolaryngology-Head and Neck Surgery
|
Street address |
7-3-1 Hongo
|
City |
Bunkyo-ku |
State/province |
Tokyo |
ZIP/Postal code |
113-0033 |
Country |
Japan |
|
|
Platform ID |
GPL10999 |
Series (1) |
GSE53357 |
Genome-wide screening for ELF4-binding sites. |
|
Relations |
BioSample |
SAMN02444805 |
SRA |
SRX392689 |